These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3275069)

  • 1. Head and neck cancer patients benefit from accelerated radiotherapy.
    Oncology (Williston Park); 1988 Sep; 2(9):65. PubMed ID: 3275069
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
    Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent Taxol and split-course accelerated radiotherapy for advanced head and neck cancer.
    Plasswilm L; Kirschner M; Sauer R
    Strahlenther Onkol; 1996 Oct; 172(10):573-9. PubMed ID: 8899009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irradiation impairment of umami taste in patients with head and neck cancer.
    Shi HB; Masuda M; Umezaki T; Kuratomi Y; Kumamoto Y; Yamamoto T; Komiyama S
    Auris Nasus Larynx; 2004 Dec; 31(4):401-6. PubMed ID: 15571914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
    Horiot JC; Bontemps P; Begg AC; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M
    Bull Cancer Radiother; 1996; 83(4):314-20. PubMed ID: 9081333
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiotherapy for postoperative persistent cancer of the head and neck.
    Hoover SV; Moss WT
    Otolaryngol Clin North Am; 1974 Feb; 7(1):175-92. PubMed ID: 4360034
    [No Abstract]   [Full Text] [Related]  

  • 12. Conformal radiotherapy in head and neck tumors: increased tumor control and decreased morbidity?
    Grégoire V; Gilbeau L
    Acta Otorhinolaryngol Belg; 1999; 53(3):231-6. PubMed ID: 10635399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ideas on fractionation and accelerated radiotherapy.
    Hall D
    Nurs Times; 1995 Mar 22-8; 91(12):42-3. PubMed ID: 7716039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma.
    Temam S; Pape E; Janot F; Wibault P; Julieron M; Lusinchi A; Mamelle G; Marandas P; Luboinski B; Bourhis J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1078-83. PubMed ID: 15990011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.
    Overgaard J; Alsner J; Eriksen J; Horsman MR; Grau C
    Rays; 2000; 25(3):313-9. PubMed ID: 11367896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High energy electron beam therapy for head and neck cancer.
    Brizel HE; Scott RM; Davis LT; Jacobson A
    J Can Assoc Radiol; 1968 Sep; 19(3):112-6. PubMed ID: 4972433
    [No Abstract]   [Full Text] [Related]  

  • 18. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Elective radiotherapy of the cervical region in carcinoma of the head and neck.
    Evers WT
    Radiol Clin Biol; 1974; 43(3):268-70. PubMed ID: 4204988
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.